Transcat News Releases

  1. Transcat Announces Additions to Board of Directors

    ROCHESTER, NY, May 13, 2021 – Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading provider of accredited calibration, repair, inspection and laboratory instrument services and value-added distributor of professional grade handheld test, measurement and control instrumentation, announced the appointments of Craig D. Cairns and Mbago M. Kaniki to its Board of Directors, effective May 12, 2021. These additions fill the vacancies that were created by the retirement of John Smith in January 2021 and Alan Resnick, who departed from the Board in September 2020. Both new Directors are considered independent.

    Read more »
  2. Transcat Announces Fourth Quarter and Full Fiscal Year 2021 Conference Call and Webcast

    ROCHESTER, NY, May 5, 2021 – Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading provider of accredited calibration, repair, inspection and laboratory instrument services and value-added distributor of professional grade handheld test, measurement and control instrumentation, announced that it will release its fourth quarter and full fiscal year 2021 results after the close of financial markets on Tuesday, May 18, 2021.

    Read more »
  3. Transcat, Inc. to Present at Sidoti Spring 2021 Virtual Conference

    ROCHESTER, NY, March 17, 2021 – Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading provider of accredited calibration, repair, inspection and laboratory instrument services and value-added distributor of professional grade handheld test, measurement and control instrumentation, announced that Lee D. Rudow, President and Chief Executive Officer, and Mark A. Doheny, Chief Financial Officer, will present and be available for investor meetings at the Sidoti Spring 2021 Virtual Conference on Wednesday, March 24, 2021.

    Read more »
  4. Transcat Reports Third Quarter Operating Income Increase of 20% on Solid Service Organic Growth and Gross Margin Expansion

    • Total revenue of $44.1 million up 2% from prior-year period in an environment that continues to be impacted by the COVID-19 pandemic
    • Service segment organic revenue growth of 5.9%; Total Service revenue up 12.2%
    • Service segment gross margin expanded 590 basis points to 27.9%
    Read more »
  5. Transcat Announces Third Quarter Fiscal Year 2021 Conference Call and Webcast

    ROCHESTER, NY, January 20, 2021 – Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading provider of accredited calibration, repair, inspection and laboratory instrument services and value-added distributor of professional grade handheld test, measurement and control instrumentation, announced that it will release its third quarter fiscal year 2021 results after the close of financial markets on Tuesday, February 2, 2021.

    Read more »
  6. Transcat, Inc. Expands Life Science Market Penetration with BioTek Services, Inc. Acquisition

    ROCHESTER, NY, December 16, 2020 – Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading provider of accredited calibration, repair, inspection and laboratory instrument services and value-added distributor of professional grade handheld test, measurement and control instrumentation, announced that it has acquired substantially all of the assets of BioTek Services, Inc. (“BioTek”), effective December 16, 2020. The purchase price was $3.5 million and is subject to certain customary holdback provisions.

    Read more »
  7. Transcat, Inc. Increases Shelf Registration to $75 million

    ROCHESTER, NY, November 17, 2020 – Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading provider of accredited calibration, repair, inspection and laboratory instrument services and value-added distributor of professional grade handheld test, measurement and control instrumentation, announced that it has filed a new shelf registration statement on Form S-3 with the United States Securities and Exchange Commission (“SEC”) to replace its previous shelf registration statement, which expires on December 17, 2020. The registration statement was filed on November 17, 2020 and will become effective upon successful review by the SEC.

    Read more »
  8. Transcat Appoints Mark A. Doheny as Chief Financial Officer

    ROCHESTER, NY, November 10, 2020 – Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading provider of accredited calibration, repair, inspection and laboratory instrument services and value-added distributor of professional grade handheld test, measurement and control instrumentation, announced the appointment of Mark A. Doheny as Chief Financial Officer. Mr. Doheny succeeds Michael J. Tschiderer, who will provide support as needed until his retirement from Transcat at the end of the calendar year.

    Read more »
  9. Transcat Reports Record Second Quarter Operating Income of $3.1 Million on Strong Service Gross Margin

    • Consolidated gross margin up 260 basis points to 27.6% driven by impressive Service segment gross margin of 32.2%
    • Total revenue of $41.6 million consistent with prior-year period in a challenging market environment; Service segment achieved 46th consecutive quarter of year-over-year growth
    • Quarterly cash from operations of $8.5 million; debt reduced by $5.8 million
    Read more »
  10. Transcat Announces Second Quarter Fiscal Year 2021 Conference Call and Webcast

    ROCHESTER, NY, October 14, 2020 – Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading provider of accredited calibration, repair, inspection and laboratory instrument services and value-added distributor of professional grade handheld test, measurement and control instrumentation, announced that it will release its second quarter fiscal year 2021 results after the close of financial markets on Tuesday, October 27, 2020.

    Read more »